| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Benaim Ely serves as a Chief Medical Officer at NVCR and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 26 sells. Those positions are worth an estimated $1.8M at current prices.
Historically, Benaim Ely's trades have earned a strong insider score of 73/100 across 14 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +38.0%.
The biggest single holding is NVCR (~$1.8M) as Chief Medical Officer. The recent filings there lean toward selling, a net 44,366 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 5,959 | $73.73 | $439,327.67 | -17.2% | +0.7% | -60.0% | |
| Aug 2, 2022 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 437 | $69.66 | $30,440.98 | -1.2% | +0.7% | -57.1% | |
| May 11, 2022 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 4,205 | $63.17 | $265,645.81 | -10.8% | +32.5% | +26.3% | |
| Mar 4, 2022 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 2,313 | $71.83 | $166,136.46 | -5.1% | +22.4% | +12.5% | |
| Aug 3, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 464 | $150.11 | $69,651.04 | -1.6% | -27.6% | -51.2% | |
| Aug 2, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 1,187 | $154.63 | $183,549.57 | -4.0% | -28.4% | -53.4% | |
| May 27, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 1,833 | $200.00 | $366,600.00 | -5.9% | -32.5% | -58.3% | |
| May 12, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sell | 1,943 | $180.48 | $350,672.64 | -6.3% | -20.9% | -66.2% | |
| May 11, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 4,095 | $184.38 | $755,055.37 | -11.7% | -20.5% | -69.0% | |
| Apr 13, 2021 | NVCR Novocure Ltd | Chief Medical Officer | Sale+OE | 5,958 | $200.00 | $1,191,600.00 | -15.2% | -2.9% | -56.0% |